EWMA-CICA 2022 Congress in Paris
The BIOVOTEC team participated at the EWMA-CICA 2022 congress in Paris on the 23-25th March 2022…
EWMA & Journées Cicatrisations
Biovotec is happy to annonce its participation to the main European Wound Healing conference…
European Innovation Council Summit
Biovotec was proud to be part of the European Innovation Council Summit 21 in November 2021 at Brussels…
New milestone achieved in with CE marking
New milestone achieved in with CE marking dossier submission to the notified body…
Biovotec team has participated to the conference “Journées Cicatrisations 2020” in Paris
This event is the biggest annual French Wound Care congress with more than 2000 visitors…
Biovotec Obtains Fast Track to Innovation EU Grant
Biovotec has been awarded a Fast Track to Innovation grant under the SME Instrument financing scheme of the Horizon 2020…
Biovotec has been registered as part of Norway green technology
Biovotec has been registered as part of Norway green technology…
Letter to the Shareholders – November 2018
We would like to use this opportunity to inform you that we have now started the human clinical safety trial in UK and the first patients are now enrolled…
Letter to the Shareholders – June 2018
We are very pleased to announce that we late yesterday received the permission from MHRA (UK health authorities) to start the CE mark human trial…